Apnat?60 mg consists of Apalutamide as its active ingredient. It is an anti-cancer drug that belongs to the androgen receptor inhibitors class of medications. It is indicated for treating patients with certain types of prostate cancer whose cancer has spread to other parts of the body and still responds to a medical or surgical treatment that lowers testosterone (male reproductive hormone) or whose cancer has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone.

Apnat?60 mg works by stopping the effects of androgen (male reproductive hormone) from stopping the growth or spread of cancer cells. Inform your physician if you have any symptoms of chest pain, indigestion, heart attack, trouble walking, and numbness in the face and body. It is not recommended for pregnant women because this may cause harm to their unborn baby. This medication may be taken with or without food. This medicine may cause fertility problems in males. Males should not become fathers or donate sperm during the treatment and for 3 months after the last done.? Use effective birth control methods.

Dasanat 50mg tablet consists of the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase and Ph+ acute lymphoblastic leukemia in patients resistant to other therapies. Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body produce too many white blood cells that happen due to alteration in the Philadelphia chromosome. Acute Lymphoblastic Leukemia is the most common form of blood cancer that affects children. In this case, the lymphocytes of white blood cells multiply too quickly and live too long.

Geftib 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.